Geron Corporation appointed Dawn C. Bir and Elizabeth G. O’Farrell as independent members of its Board of Directors. In addition, Ms. Bir will serve as a member of the Board Nominating and Corporate Governance Committee, and Ms. O’Farrell will serve as a member of the Board Audit Committee. Dawn C. Bir currently serves as the Chief Commercial Officer of Reata Pharmaceuticals, where she leads marketing, market access, sales and commercial operations. Elizabeth G. O’Farrell most recently served as Chief Procurement Officer and Head of Global Shared Services at Eli Lilly and Company.